580
Participants
Start Date
October 8, 2012
Primary Completion Date
January 1, 2014
Study Completion Date
January 18, 2014
Mepolizumab IV
Mepolizumab 75 mg IV will be administered every 4 weeks with the last dose at Week 28
Mepolizumab SC
Mepolizumab 100 mg SC will be administered every 4 weeks with the last dose at Week 28
IV Placebo
Normal saline (placebo) will be administered IV every 4 weeks with the last dose at Week 28
SC Placebo
Normal saline (placebo) will be administered SC every 4 weeks with the last dose at Week 28
GSK Investigational Site, Brussels
GSK Investigational Site, New Lambton
GSK Investigational Site, Leuven
GSK Investigational Site, Parkville
GSK Investigational Site, Clayton
GSK Investigational Site, Liège
GSK Investigational Site, Bedford Park
GSK Investigational Site, Mendoza
GSK Investigational Site, San Rafael
GSK Investigational Site, Nedlands
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Ghent
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Marseille
GSK Investigational Site, México DF
GSK Investigational Site, Potsdam
GSK Investigational Site, Rochester
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Genoa
GSK Investigational Site, Pietra Ligure (SV)
GSK Investigational Site, Hershey
GSK Investigational Site, Vinnytsia
GSK Investigational Site, Baltimore
GSK Investigational Site, Hamburg
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Durham
GSK Investigational Site, Pozuelo de Alarcón/Madrid
GSK Investigational Site, Albany
GSK Investigational Site, Montpellier
GSK Investigational Site, Cittadella PD
GSK Investigational Site, Birmingham
GSK Investigational Site, Nashville
GSK Investigational Site, Magdeburg
GSK Investigational Site, Parma
GSK Investigational Site, Columbus
GSK Investigational Site, Cleveland
GSK Investigational Site, Zapopan
GSK Investigational Site, Zapopan
GSK Investigational Site, Cincinnati
GSK Investigational Site, Cincinnati
GSK Investigational Site, Mykolayiv
GSK Investigational Site, Mainz
GSK Investigational Site, Rochester
GSK Investigational Site, Pisa
GSK Investigational Site, Lille
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Chicago
GSK Investigational Site, Kharkiv
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Gelnhausen
GSK Investigational Site, Aschaffenburg
GSK Investigational Site, Monterrey
GSK Investigational Site, Perpignan
GSK Investigational Site, Lyon
GSK Investigational Site, Foggia
GSK Investigational Site, Napoli
GSK Investigational Site, Denver
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Riverside
GSK Investigational Site, Newport Beach
GSK Investigational Site, Le Kremlin-Bicêtre
GSK Investigational Site, Saint-Pierre
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Donggu Gwangju
GSK Investigational Site, Rancagua
GSK Investigational Site, Talcahuano
GSK Investigational Site, Santiago
GSK Investigational Site, New Haven
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Rosario
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Calgary
GSK Investigational Site, Edmonton
GSK Investigational Site, Vancouver
GSK Investigational Site, Winnipeg
GSK Investigational Site, Burlington
GSK Investigational Site, Hamilton
GSK Investigational Site, Windsor
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Saint-Charles-Borromée
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Perugia
GSK Investigational Site, Chiba
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Gunma
GSK Investigational Site, Hiroshima
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hyōgo
GSK Investigational Site, Hyōgo
GSK Investigational Site, Ibaraki
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kumamoto
GSK Investigational Site, Mie
GSK Investigational Site, Okinawa
GSK Investigational Site, Okinawa
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Anyang-si
GSK Investigational Site, Bucheon-si
GSK Investigational Site, Cheongju, Chungcheongbuk-do
GSK Investigational Site, Daegu
GSK Investigational Site, Incheon
GSK Investigational Site, Jeonju-si, Jeollabuk-Do
GSK Investigational Site, Kangwon-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon, Kyonggi-do
GSK Investigational Site, Alicante
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Kiev
GSK Investigational Site, Bradford
GSK Investigational Site, Glasgow
GSK Investigational Site, London
GSK Investigational Site, Plymouth
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY